EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
For the General Assembly in June, we need to prepare an update about the CTF project for delegates. This update should contain:
In addition, delegates should receive the 3 competency frameworks (the long, the medium-long and the short version) that we have created. In relation to WG1, we need to discuss what can be presented to the GA, since WG1 is currently not moving forward with its activities due to the lack of a chair. An essential document that should be share with GA delegates would be the comparison exercise between the national training programmes and the CTF competency framework.
The European Medicines Agency (EMA) has pointed out to us that it finds our position paper very valuable. However, EMA noticed that footnotes 1, 7, 10 and 11 refer to two old communications. In May 2017, EMA adopted a new communication on biosimilar medicines (“Biosimilars in the EU – Information guide for healthcare professionals”) which the agency finds very valuable. In addition, EMA also suggested to include a reference to the guide in the section “information on biosimilar medicines” since the guide elaborates on the terms and concepts mentioned in this section. This request could be addressed by including an additional footnote in this section referring to the information guide.
As discussed during the last Board meeting, EMA asked us to update the Biosimilar Medicines Position Paper. Please find HERE the updated documents. The changes included in the document are highlighted in yellow for the convenience of the GA delegates. The same procedure was done last year in relation to the update of the eHealth/mHealth position paper.
An update of the AMR position paper would provide us on the one hand the opportunity to put antimicrobial stewardship a bit more in the focus. On the other hand, we could align our paper with the current priorities of the European Commission (i.e. pharmaceutical in the environment and the new One Health Action plan). Since AMR is one of our main priorities an update should be considered. Please find some initial ideas for an update HERE
During the last Board meeting it was decided to start the development of a Procurement Position Paper. The field of procurement is quite large, wherefore we need to agree on a direction for our position paper. The following document (HERE) outlines ideas for our position paper.
